Our NRLN partner protects retirees.Click HERE to sign up for emails. Click the flaming ACTION ALERT icon to make your voice heard in Washington DC. Click on NRLN to go to our website.

action alert


Please become an individual contributor to the DuPont Retirees Chapter and the National Retiree Legislative Network by making an annual financial contribution of $25, $50, $75 or more. Any amount you can contribute will be appreciated. You may make your check or money order payable to NRLN, Inc. and mail it with the Contribution Form below. Or, make your contribution with your credit card on the NRLN website at

National Retiree Legislation Network – DuPont Retirees Chapter Contribution Form

The NRLN is a nonprofit, tax-exempt organization. Contributions are not tax deductible.

Name: _______________________________________

Age: __under 55; __ 55-64; __ 65 or over

Address: __________________________

City: _________________State: ___Zip: _______Zip + 4: ____

Phone: ___________________

Email Address (if available):

Mail this form with your check or money order (no cash please) for $25, $50, $75 or more (any amount will be appreciated) payable to NRLN, Inc., P.O. Box 18757, Washington, D.C. 20036-8757


NRLN information particularly relevant to DuPont Retirees Chapter; Action Alerts; Enrollment instructions

NRLN gains ground on two major health care issues!

For the last four years the NRLN and our grassroots advocates have lobbied to get movement on lowering the cost of safe prescription drugs by importation and Medicare being allowed by law to do competitive bidding on behalf on Medicare Part D participants.

At a town hall meeting the NRLN arranged on August 26 with Rep. Kevin Brady (TX-08), Chairman of the House Ways and Means Committee, we learned that when Congress passed the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 that It gave the Secretary of the Department of Health and Human Services the authority to set regulations to import prescription drugs from Canada. On September 6, I sent a letter to HHS Secretary Sylvia Mathews Burwell urging her to exercise the authority given to the HHS Secretary in the 2003 law to authorize importation of prescription drugs from Canada.

A version of that letter was presented in more than 60 meetings with Representatives, Senators and/or members of their staffs during the NRLN’s Fall Fly-In, September 27 and 28. During each appointment the request was made that the letter, or a rewritten version, be sent to Secretary Burwell. We asked that the Representative or Senator get additional signatures from his or her colleagues.

It turned out that 33 Representatives stepped up the game beyond our request. They signed an October 12 letter that asked President Obama to:

  • Explore implementing drug importation under the Medicare Prescription Drug Improvement and Modernization Act of 2003 that gave this authority to the Secretary of Health and Human Services.
  • Instruct the Director of the National Institutes of Health to ensure that drugs researched and developed with taxpayer funds are kept accessible to the public by authorizing new competition for unaffordable, monopoly-priced medications. (The NRLN had lobbied for this on Capitol Hill during out February 2016 conference.)
  • Address reforms to more effectively combat pharmaceutical companies from blocking generic drug competition through the practice known as pay-for-delay.(This is part of the NRLN’s Legislative Agenda that we have been lobbying for with members of Congress.)

For the past three years, the NRLN and our grassroots advocates have been lobbying for legislation to eliminate Medicare’s 3-day “inpatient” requirement in order for Medicare beneficiaries to qualify for coverage of skilled nursing facility (SNF) services. Under the current Medicare payment policy, for SNF services to be covered by Medicare, the beneficiary must have an “inpatient” hospital stay of at least 3 days. Beneficiaries are often unaware that the hospital has admitted them for “observation” rather than as an “inpatient”. Those admitted for “observation” who later receive SNF services are surprised when they are billed for the services.

This week Michigan Senator Gary Peters cosponsored a bipartisan bill that, if passed, would to fix the current law and ensure the classification of a hospital stay does not increase cost for Medicare beneficiaries needing specialized care in a skilled nursing facility.

The National Retiree Legislative Network and the National Chrysler Retirement Organization (NCRO) were among the retirement advocacy organizations, including AARP, given credit in Senator Peters’ press release for supporting the introduction of the bill. The NRLN credits NRLN director Jay Kuhnie, NCRO President, Deb Morrissett, NCRO Director, Bob Tompkins, NRLN Treasurer and Detroit Edison of Retirees (DEAR) President, and Larry Hice, General Motors Retirees Chapter President and their team who have lobbied for the elimination of Medicare’s 3-day rule during a number of appointments with Senator Peters during the NRLN’s Washington, DC meetings.

What I have described above are the latest examples of the ground that can be gain by being relentless in lobbying for issues important to retirees. Of course, we will have to continue to follow up in order to achieve what has been asked of President Obama by the 33 Representatives (and hopefully more to come). The Action Alert sent out this week on this issue was our first step. The NRLN’s Legislative Affairs Committee and Legislative Action Planning Committee will track the bill to eliminate Medicare’s 3-day rulel. I’ll let you know if your help is needed to lobby for passage of the bill, which does not yet have a number.

Bill Kadereit, President,
National Retirees Legislative Network

NRLN Action Alert

Stop the Effort to Privatize Medicare

Tell your members of Congress stop the effort to privatize Medicare through a “premium support” plan that seniors would pay to insurance companies. This would certainly lead to seniors paying more for health care. Please email the NRLN’s sample letter to your Representative and Senators to urge them to prevent the privatization of Medicare.

Here are the easy steps to follow on this Action Alert:

The link will present the sample letters for you to email to President Barack and a copy to your U.S. Representative and U.S. Senators. If you have a problem with the link, go to and click on the “Take Action Now!” near the top of the NRLN website home page. When the Action Alert appears, click on the “Write your Legislators” link.

When you have accessed the sample letter, to the left of the letter are windows to type in your contact information required by the President and members of Congress so they know they are receiving an email from a constituent. If you have sent previous NRLN emails to your members of Congress your contact information may be automatically displayed.

Personalize the letters by editing in your own comments.

Click on the "Preview" button and the letters addressed to President Obama and your Representative and two Senators will appear. Their names will be automatically added in the letter’s greeting. Check to make sure the letters to your members of Congress appear correct and then click "Send".


Read Article on Results of NRLN 2016 Future Directions Survey

Message from the NRLN President

DuPont Current and Future Retirees,

I want to extend to you a warm welcome as a newly formed Chapter of the NRLN.

The NRLN is a non-profit, non-partisan, grassroots coalition representing the interests of more than 2 million retirees, who came to the NRLN from retiree associations, NRLN chapters and individual members who have retired from nearly 200 different U.S. corporations and public entities. Members live in all 50 states and practically all Congressional districts and are working together to preserve the retirement benefits they earned during their many years of productive employment.

The NRLN does not provide legal advice. Nor does NRLN interface with employers, representing their retirees. It is up to Chapters to handle any communications with their former employers as they wish. However, the NRLN does provide services which are very valuable - namely the ability to communicate with members of Congress and Congressional committees that have oversight of retirement issues and with federal agencies that have the responsibility to protect the interests of retirees. In addition, the NRLN knows the requirements of the Employee Retirement Income Security Act.

The NRLN's staff in Washington, DC uses the rapport they have with U.S. Representatives and Senators and their staff members as a communications channel to advance legislation important to retirees. In addition we sit on critical advocacy group committees that include AARP, the ERISA Industrial Council, Pension Rights Center and other groups that meet regularly with House and Senate key committees with jurisdiction over retiree legislation.

While the NRLN and AARP cooperate on a number of issues, what differentiates the NRLN is that we work directly with our Chapters and Retiree Associations in problem solving on pension issues. When necessary the NRLN facilitates and accompanies leaders of its member organizations for meetings with the Pension Benefits Guaranty Corporation (PBGC), Department of Treasury, Department of Labor, Employee Benefits Security Administration, staff members of Representatives and Senators and staffs of Congressional committees.

Based in Washington, D.C., the NRLN is the only nationwide organization solely dedicated to representing the interests of retirees and future retirees. Formed in 2002, the NRLN endeavors to secure federal legislation for retirement income security and reduce the cost of health care along with keeping Social Security and Medicare strong.

You are encouraged to learn more about the NRLN by taking the time to browse this NRLN website. Click on the Home Page link and navigate this website through the use of the tabs and the drop down menus. Be sure to review the Legislative Agenda and go to the Archives and read a few of the back issues of the FOCUS newsletter.

Bill Kadereit, President
National Retiree Legislative Network

NRLN Action Alert: Tell Congress: Don’t Eliminate SHIP Needed for Medicare Advice

The Senate Appropriations Committee made a blunder when it voted to abolish the entire $52.1 million in federal funding for the State Health Insurance Assistance Program (SHIP) in the budget bill. SHIP has been a valuable program for older adults and younger people with disabilities who need advice on complex traditional Medicare, Medicare Supplemental Insurance (Medigap) and Medicare Advantage programs. This has the effect of leaving these citizens at the mercy of the private insurance companies who may increase premiums or deductibles and may change physician provider networks at will. With the huge influx of Americans turning 65, killing the SHIP program is a classic example of Congressional short-sightedness. Click here to take action to email the NRLN’s sample letters to tell your members of Congress to restore SHIP funding.

Enroll in DuPont Retirees Chapter

If you have not already received one or more emails from the DuPont Retirees Chapter, sign up through this website. Click here to access the sign up webpage. After entering your contact information, open the Name of Retiree Association or Chapter window, scroll down to the bottom of the list and select NRLN DuPont Retirees Chapter. Next click the box to also receive NRLN emails. Finalize your sign up by clicking SIGN ME UP.


Chapter history and activities; current and archived communications with DuPont management, concerning retiree benefit issues, are just the opinions of the writers.

Jim Odle (right), President, NRLN DuPont Chapter, with Brian Winseck, staff member for Sen. Chris Coons (DE)

March 20, 2017

To: NRLN DuPont Retiree Chapter Members
Report on NRLN Fly-In Event in Washington on March 13-15, 2017

I attended the Spring NRLN (National Retiree Legislative Network) Fly-In event in Washington, DC on March 13-15. About 30 retirees from all over the U.S. attended and met with members of Congress to advocate for legislation protecting retiree income and benefits and to reduce the skyrocketing cost of prescription drugs. Three of the four focus areas for this event were the same as last fall's event, with one new area - the protection of retiree benefits in bankruptcies.

An unexpected snowstorm caused confusion and some meetings had to be re-scheduled or canceled, however, in the end it turned out to be a productive event. I have learned from last year's experience and from discussions with NRLN executives not to expect quick actions on newly proposed legislation, rather that lobbying requires patience and persistence, more like a marathon than a sprint race.

The following is a high-level summary of the legislative proposals (See links below to more detailed information) we presented to the Congressional Delegations:
  1. NRLN urges passage of proposed legislation now in Congress:
    • S. 41 and H.R. 242, the Medicare Prescription Drug Price Negotiation Act of 2017, which would reduce the cost of prescription drugs by allowing Medicare to negotiate the best possible price of prescription drugs.
    • S. 92, the Safe and Affordable Drugs from Canada Act of 2017, to allow individuals to import a 90-day supply of prescription drugs from an approved Canadian pharmacy.
    • S. 469 and H.R. 1245, the Affordable and Safe Prescription Drug Importation Act of 2017, would lower cost of prescription drugs by allowing Americans to import safe, low-cost medicine from Canada and
    • would authorize the HHS Secretary in two years to allow importation from other advanced countries.
    • S. 124, the Preserve Access to Affordable Generics Act of 2017, to expand consumers’ access to the cost-saving generic drugs and increase competition between drug manufacturers to end “pay for delay” deals—the practice of brand-name drug manufacturers using anti-competitive pay-off agreements to keep more affordable generic equivalents off the market.
    • In addition, the Secretary of Health and Human Services has the authority (under the Medicare Prescription Drug, Improvement and Modernization Act of 2003) to issue an order to begin legal importation from Canada. We submitted an NRLN composed letter to our representatives to send to the Secretary, urging him to exercise this authority. Three Senators (Grassley, McCain and Klobucher) have already done this. Members of Congress who have opposed importation from Canada have cited drug safety concerns. However, the NRLN believes that this could be managed. After all we import foodstuffs from all over the world and the FDA has managed to keep us safe from bad food.
  2. NRLN’s proposals to provide protections for pension plan participants in pension plan mergers: While plan mergers can be beneficial by reducing administrative expenses, and increasing the fund's ability to get better returns, the NRLN is concerned about a form of financial engineering whereby plan sponsors have combined two (or more) plans, some better funded than others. If the merged plan then becomes funded above the 80% level the required minimum contribution is reduced. This harms participants in the better funded plan. NRLN proposes legislation to require plan sponsors to give notice of impending mergers to the PBGC, and that PBGC should have the authority to approve or disapprove plan mergers, and that the plan merger should not reduce the required plan minimum contribution for a period of 5 years.
  3. NRLN's proposals to provide protections for pension plan participants in corporate mergers, acquisitions and spin-offs: Corporate mergers, acquisitions and spin-offs can result in several situations that harm pension plan beneficiaries. Activity in this area involving foreign firms is especially risky to pension plan participants. NRLN proposes to update several ERISA provisions to ensure that these activities do not unnecessarily increase the risk of a distress termination and pension losses for plan participants.
  4. NRLN's proposals for bankruptcy law reform to protect benefits in corporate bankruptcies: Many NRLN members have lost and/or are facing loss of benefits due to corporate bankruptcies (for example, Kodak, Chrysler, Avaya, Delphi, etc.) and some related their experiences at the meeting. NRLN proposes strengthening current bankruptcy codes to give retirees higher status in bankruptcy courts, comparable to the status of secured creditors. Although at present this does not seem to be a concern for DuPont retirees, we never know what might happen when the merged company splits into three, or when the future companies decide to sell off under-performing businesses.

Our proposals were well developed, in concise but comprehensive packages, with Executive Summaries and legislative language to facilitate amendments to existing laws. You can review the key documents in full detail at under the Legislative Agenda tab or by going directly to this link. The Talking Points were used to guide our discussion, and the Executive Summaries along with suggested language for amendments, were left behind for our legislators to review and decide whether they will support them.

Although Representatives and Senators were very busy with hearings and other activities related to the incoming administration, I was able to meet with staff members of Delaware Senator Coons (see attached photo) and West Virginia Senator Manchin. I was not able to arrange a meeting with Delaware's Senator Carper nor was I able to meet with Delaware's new Representative Lisa Blunt Rochester (I am working to schedule a phone call or meeting in Delaware with her). I chose to meet with Manchin's staff because he represents many DuPont Retirees. In the future, I hope to meet with members of Congress from other states with large numbers of DuPont retirees.

With political gridlock, we cannot reasonably expect rapid action on any legislative proposals. However, our proposals are not especially politically sensitive or controversial, and our representatives and their staffs seemed keenly interested in them. The prescription drug issue may be one area that we will get some action on in the coming year. Many members of Congress are in favor of our proposals and the President has expressed his support for allowing Medicare to negotiate drug prices and for importation of medicines. I encourage you to contact your own members of Congress and advocate for action on this issue as well as the others. You can find your Legislator's support or non-support for these issues here.

You can send them a message at either their website or at this link.

Creating legislative change is difficult and slow, but we can’t expect progress if we don’t try. We will continue to press our politicians to improve the legal protection of retirees’ income security, because we know from the experience of others, that when companies restructure businesses, post-merger / split decisions can lead to significant adjustments to retiree pension and healthcare benefits. I am looking forward to attending the September NRLN Annual Leadership Conference in Washington, DC, and going to Capitol Hill again to advocate for issues important to all retirees.

Please feel free to contact me with any questions or comments.

Jim Odle, President, DuPont Retirees Chapter
National Retirees Legislative Network


Welcome Message from Chapter President - 7/25/2016

Report on Capitol Hill Lobbying Session, and a Request for Feedback (10/23/16)

DuPont U.S. Retiree Benefits Website | DuPont USA This is the place for DuPont’s U.S. retirees to access the most up-to-date information about your DuPont benefits. Materials include the latest information.

Expanding on Wilmington News Journal Article about DuPont Pensions December 8, 2016

Company Paid Survivor Benefit 2/6/2017

Help Spread the Word on NRLN DuPont Retirees Chapter 1/7/2017

Update on Pension Security 11/21/16

Chapter Update - 08/12/2016

Chapter Proposal Cover Letter - 7/5/16

Chapter Proposal - 7/5/16

DuPont Factsheet SEC Filing 5/25/16

Email on 5/25/2016

Status Report - 5/2/16

Cover Note for Letter to DuPont - 3/28/16

Letter to DuPont Executives- 3/25/16

DuPont’s Letter to Pension Plan Participants – February 2016


Current and archived media articles about DuPont retiree benefits, corporate restructuring, and other information, with potential impact on Company financial conditions – without comment. Some publications (e.g. The Wilmington News Journal/Delaware Online), may permit only limited viewing of articles without a subscription.

DuPont's first quarter results beat estimates
By Jeff Mordock; The News Journal ~ Apr 25, 2017

DuPont Settlement Causing Controversy with Waynesboro Officials
By Megan Mathewson; NBC 29 ~  Apr 23, 2017


DuPont Settlement Causing Controversy with Waynesboro Officials
By Megan Mathewson; NBC 29 ~ Apr 23, 2017

DuPont's River Contamination Settlement Details Finalized
NBC29 ~ Apr 22, 2017

DuPont, University of Delaware, state officials to launch business incubator
By Scott Goss & Jeff Mordock; The News Journal ~ Apr 21, 2017

Plaintiffs allege DuPont spent more on attorney than C8 tests
By Jeff Mordock; The News Journal ~ Apr 17, 2017

DuPont's 'game changer' Tyvek turns 50
By Jeff Murdock, The News Journal - Apr 14, 2017

DuPont, Dow push back merger date
The Associated Press ~ Mar 31, 2017

Dupont to Purchase Rockland Plant in Agreement
By Ed Morin; Maine Public ~ Mar 31, 2017

DuPont sells part of Stine-Haskell to FMC, saving 600 jobs
By Jeff Mordock; The News Journal ~ Mar 31, 2017

Dow and DuPont Announce Amendments to Transaction Merger Agreement
News Release – March 31, 2017

Farmers Union urges administration to oppose Dow-DuPont merger
By “Agweek Wire Report” ; Agweek ~ Mar 29, 2017

Dow-DuPont Deal Wins Conditional Antitrust Approval From EU
By Aoife White, Bloomberg – March 27, 2017

EU approval boosts Dow-DuPont merger hopes
By Jeff Mordock; The News Journal ~ Mar 27, 2017

Will The Dow/DuPont Merger Close In Q2?
By John Abbink, Seeking Alpha – March 25, 2017

DuPont heirs' pension suit transferred to Delaware
By Jeff Mordock ; The News Journal ~ Mar 21, 2017

Dow & DuPont: The Time to Buy is Now
By Ben Levisohn; Barron’s ~ Mar 06, 2017

Hygiena completes purchase of DuPont unit
By Jeff Mordock; The News Journal ~ Mar 02, 2017

DuPont stock hits 20-year high amid EU approval reports
By Jeff Mordock, The News Journal – Feb 24, 2017

DuPont moving some Kevlar production to Richmond when it closes South Carolina plant
By John Reid Blackwell; Richmond Times-Dispatch ~ Feb 24, 2017

DuPont to close most of Cypress Gardens Road plant; 113 employees affected
By Lindsay Street; The Berkeley Independent ~ Feb 23, 2017

GM, PSA Haggling Over $9 Billion Pension Gap
Industry Week - Feb 22, 2017

Dow-DuPont deal close to winning EU approval
By Carl Surran, Bloomberg - Feb 22, 2017

DuPont settles lawsuits over Teflon-making chemical leak
By Arathy S Nair; Reuters ~ Feb 13, 2017

DuPont Reaches Global Settlement of Multi-District PFOA Litigation
DuPont Investor News – Feb 13, 2017

Dow, DuPont offer to sell businesses to win EU merger approval
By Jeff Mordock; The News Journal ~ Feb 08, 2017

Retirees question DuPont pension funding
By Jeff Mordock; The News Journal ~ Feb 06, 2017

DuPont to contribute $325 million to DB plans in 2017
By Hazel Bradford; Pensions & Investments ~ Feb 03, 2017

Ex-Ag Secretaries Back Dow-DuPont Merger
By Chris Clayton, DTN/Progressive Farmer - Jan 31, 2017

Era ends, DuPont sells its hotel
By Jeff Mordock, The News Journal – Jan 31, 2017

DuPont declares 2017 dividend
By Jeff Mordock ; The News Journal ~ Jan 30, 2017

DuPont CEO Gives Investors Confidence Dow Deal Is on Track
By Jack Kaskey; Bloomberg ~ Jan 24, 2017

DuPont Reports Fourth-Quarter and Full-Year Results
DuPont Website – Jan 24, 2017

DuPont warns of merger delay, reports strong quarter
By Jeff Mordock, The News Journal - Jan 24, 2017

EU Review of Dow-DuPont Deal Could Come Down to Innovation
By Meagan Parrish, ChemInfo - Jan 18 2017

Carper, Coons among Dems slammed for vote with drug companies
By Nicole Gaudiano, The News Journal - Jan 13, 2017

Breen: DuPont to invest $200M in Experimental Station
Jeff Mordock, The News Journal - Jan 9, 2017

Chemours to stay in 'revitalized' HQ
By Jeff Mordock, The News Journal - Jan 9, 2017

Trump Adviser Wants to Stop Megadeals Like Dow-DuPont Merger
By Meagan Parrish, ChemInfo - Jan 9, 2017

Dow, DuPont to make merger case next week to EU regulators
By Carl Surran; Seeking Alpha ~ Jan 06, 2017

DuPont must pay $10.5M in punitive damages in C-8 case
By Jeff Mordock; The News Journal ~ Jan 05, 2017

Editorial: DuPont needs to clean up its act, literally
The News Journal ~ Dec 27, 2016

'Because It is Right': DuPont engineer makes difference
By Jeff Mordock; The News Journal ~ Dec 23, 2016

New Jersey town files $1B lawsuit against DuPont
Jeff Mordock, The News Journal - Dec 22. 2016

Jury orders to DuPont to pay $2M in C-8 case
By Jeff Mordock; The News Journal ~ Dec 21, 2016  

Should You Buy the Dow? E I Du Pont De Nemours And Co (DD) Stock
By Lawrence Meyers; InvestorPlace ~ Dec 19, 2016

DuPont to pay $50 million over mercury dumped in river
By Sarah Rankin; The Associated Press ~ Dec 15, 2016

Delaware jobs to remain, increase at DuPont unit after sale

DuPont Selling Food Safety Diagnostics Unit to Hygiena
Powder & Bulk Solids ~ Dec 14, 2016

DuPont CEO Breen says Trump win unlikely to impact Dow deal
By Ross Kerber; Reuters ~ Dec 08, 2016

NCCo approves $7.5 million DuPont contribution
By Xerxes Wilson; The News Journal ~ Nov 30, 2016

Letter: 2018 Changes to the Pension Plan and Other Post-Retirement Benefits
By Benito Cachinero-Sanchez, DuPont Senior VP Human Resources

DuPont to end pension contribution for active employees
By Jeff Mordock, The News Journal - Nov 17, 2016

DuPont to freeze defined benefit plan in 2018
By Hazel Bradford; Pensions & Investments ~ Nov 17, 2016

Dow-DuPont Said to Expect EU Objections to Merger Next Month
By Gaspard Sebag & Aoife White; Bloomberg Markets ~ Nov 15, 2016

Exclusive: U.S. states join Dow-DuPont merger probe - sources
By Diana Bratz, Reuters - Nov 7, 2016

DuPont launches 12-inch flashing tape for building industry
By Jeff Mordock; The News Journal ~ Nov 08, 2016

EU Commission holds up DuPont-Dow merger review
The Associated Press ~ Nov 04, 2016

Cost cuts help DuPont survive weak sales, write downs
By Jeff Mordock; The News Journal ~ Oct 25, 2016

Forecast as Dow Merger Seen Delayed to 2017
By Jack Kaskey; Bloomberg ~ Oct 25, 2016

Dow Chemical CEO Says DuPont Merger May Be Delayed to 2017
By Rick Clough & Jack Kaskey; Bloomberg ~ Oct 25, 2016

Paid Breaks Can’t Offset Other Compensation Due, Court Says
By Kate McGovern Tornone; Compensation BLR ~ Oct 20, 2016

DuPont to face 10 C-8 trials in three months
By Jeff Mordock ; The News Journal ~ Oct 19, 2016

DuPont Said to Seek Buyer for Herbicides to Ease Merger With Dow
By Andrew Marc Noel; Bloomberg ~ Oct 14, 2016

DuPont's Breen to speak at Chamber of Commerce dinner
By Jeff Mordock ; The News Journal ~ Oct 11, 2016

Court overturns ruling for DuPont in overtime suit
By Jessica Masulli Reyes; The News Journal ~ Oct 10, 2016

5 things to know about Europe DuPont review
By Jeff Mordock , ; The News Journal ~ Oct 07, 2016

Is DuPont Counting Its Merger Chickens Before they Hatch?
By John Bromels; The Motley Fool ~ Oct 08, 2016

Europe restarts DuPont merger review
By Jeff Mordock; The News Journal ~ Oct 04, 2016

Editorial: DuPont cannot shirk pension promises
The Editors; The News Journal ~ Sep 28, 2016

Ahead of merger, DuPont retirees worry for their pensions
By Jeff Mordock, The News Journal - Sept 24, 2016

Roadblocks remain for DuPont-Dow merger
By Harry Themal; The News Journal ~ Sep 23, 2016

DuPont official defends merger in Senate hearing
By Jeff Murdock, The Journal News - Sept 20, 2016

DuPont merger Senate hearings could focus on antitrust concerns
By Jeff Mordock; The News Journal ~ Sep 19, 2016

Dissecting Dow And DuPont Deal: Concern Over Concentration
From “Trefis Team”; Forbes ~ Sep 15, 2016

DuPont to resume giving raises and promotions
By Joseph N. DiStefano; The Philadelphia Inquirer ~ Sep 15, 2016

DuPont Senate hearing scheduled for Sept. 20
By Jeff Mordock; The News Journal ~ Sep 12, 2016

EU regulators halt Dow, DuPont merger review to gather data
By Foo Yun Chee; Reuters ~ Sep 09, 2016

Could the Senate Pull the Plug on the Dow-DuPont Merger?
By John Bromels, The Motley Fool - Sept 8, 2016

Judge: clock ticking on DuPont C-8 settlement claims
Jeff Mordock; The News Journal ~ Sep 08, 2016

European Union grants 10-day extension for DuPont merger review
By Jeff Mordock; The News Journal ~ Sep 03, 2016

Dow Chemical Deal With DuPont Could Be in Trouble
By Tony Owuse, The Street - Aug 31, 2016

DuPont pension choice: 'The company has scared everybody'
By Joseph N. DiStefano; The Philadelphia Inquirer ~ Aug 29, 2016

U.S. Senate to hold Dow-DuPont merger hearings
By Jeff Mordock, The News Journal - Aug. 24, 2016

European Union reviewing DuPont-Dow merger
By Jeff Mordock, The News Journal - Aug. 16, 2016

Dow and DuPont Statement Regarding Phase II Review by European Commission
Investors.DuPont.Com - Aug. 11, 2016

Chemours to stay in Wilmington; 1,000 jobs kept in Del.
Jeff Mordock, The News Journal 7:27 a.m. EDT August 2, 2016

DuPont earnings exceed expectations
Jeff Mordock, The News Journal – July 26, 2016

Top DuPont executive may testify in C8 cases
By Jeff Mordock, The News Journal – July 25, 2016

DuPont-Dow merger approved by shareholders
By Jeff Mordock and Scott Gross, The News Journal – July 20, 2016

Collection of The News Journal Articles on DuPont

After Dow-DuPont merger, more pain or gain?
By Jeff Mordock; The News Journal ~ Jul 15, 2016

Jurors say DuPont acted with malice, award $5M to ill man
The Associated Press ~ Jul 06, 2016

Buccini/Pollin appears to be buying Hotel du Pont
By Jeff Mordock, The News Journal – Jun 28, 2016

DuPont & Dow Chemical: Odds Are Good You Can Buy Them Cheaper Later
By Ben Levisohn; Barron’s ~ Jun 28, 2016

Why Pending New Chemical Regulations Won't Hurt DuPont, Dow, or 3M
By John Bromels,TMF; Fox Business ~ Jun 28, 2016

A last-minute hurdle for Dow-DuPont deal?
By John Russell; Indianapolis Business Journal ~ Jun 17, 2016

Dow and DuPont Decide On Merger in July
WHOTV.Com – June 16, 2016

Grassley asks Justice Department to closely review Dow-DuPont deal
By Christopher Doering, Des Moines Register – June 14, 2016

Justice Department should analyze Dow-DuPont deal: senator
By Tom Polansek, Reuters – June 14, 2016

Farm groups ask feds to oppose Dow-DuPont merger
By Jeff Mordock, The News Journal – June 8, 2016

  Suggestions and comments about this website should be addressed to Last updated: April 27, 2017